Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Depisteo is a private medical device company focused on screening technologies for vision, breathing, hearing, and related preventive health applications. The company markets commercial screening devices including the VT1 4K vision screeners and the Spirolyser Q13 spirometer, and it also offers accessories, software-enabled workflows, maintenance, and support services. Depisteo operates as the U.S. subsidiary of France-based FIM Medical, which designs and manufactures the underlying products. Its solutions are used by occupational health providers, preventive medicine professionals, optometry and respiratory care users, and other healthcare settings. The business is commercial-stage rather than therapeutic drug-development focused, with revenue derived from device sales and related services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Depisteo.